In 2004 Bellberry was founded as a paradigm breaker. We are an institutionally independent not-for-profit company that offers Human Research Ethics Committee services.
Today Bellberry provides ethics reviews for more than 40% of the CTN clinical trials taking place in Australia and has re-invested $12 million into the research sector.
In 2024 we celebrated 20 years of Bellberry with a focus on the difference we’ve made since we began. This culminated with Bellberry winning the national Telstra Best of Business award for Championing Health late last year. In this episode of From Lab to Life called ‘Eye on The Prize’ we hear about the impact of Bellberry from some of our valued clients and what’s ahead from our CEO Kylie Sproston.
